Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SRD5A1 | P18405 | 1/20 | 0.44 |
| ▸ | SRD5A2 | P31213 | 1/20 | 0.44 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.43 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7527164 | 0.77 | SRD5A1 (0.58) | SRD5A1SRD5A2 | |
| SCHEMBL7802581 | 0.77 | SRD5A1 (0.58) | SRD5A1SRD5A2 | |
| SCHEMBL8682897 | 0.76 | SRD5A1 (0.42) | SRD5A1SRD5A2GRIN1GRIN2B | |
| SCHEMBL9152806 | 0.75 | SRD5A2 (0.50) | SRD5A2GRIN1GRIN2B | |
| SCHEMBL9318018 | 0.74 | CYP19A1 (0.44) | SRD5A1SRD5A2 | |
| SCHEMBL29843057 | 0.74 | CYP19A1 (0.44) | SRD5A1SRD5A2 | |
| SCHEMBL8996738 | 0.73 | SRD5A1 (0.46) | SRD5A1SRD5A2 | |
| SCHEMBL15121576 | 0.70 | AR (0.42) | SRD5A2 | |
| SCHEMBL8076029 | 0.70 | NR1I3 (0.47) | GRIN1GRIN2B | |
| Propionic Acid SCHEMBL12694801 | 0.70 | GPBAR1 (0.57) | SRD5A2GRIN1GRIN2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0792371-A4 | COMBINATION METHOD FOR ACNE TREATMENT | MERCK & CO INC (US) | 1998-12-30 | — | — | EP | disclosed |
| EP-0792371-A1 | COMBINATION METHOD FOR ACNE TREATMENT | Merck & Co., Inc. (US) | 1997-09-03 | — | — | EP | disclosed |
| WO-1996012817-A1 | COMBINATION METHOD FOR ACNE TREATMENT | MERCK & CO., INC. (US) | 1996-05-02 | — | — | WO | disclosed |